GABA receptor heterogeneity modulates dendrodendritic inhibition
Marco Sassoè-Pognetto1, Patrizia Panzanelli, Samuel Lagier
1Department of Anatomy, Pharmacology, and Forensic Medicine, and National Institute of Neuroscience-Italy, Turin, Italy. marco.sassoe@unito.it
Annals of the New York Academy of Sciences
|August 19, 2009
Summary
The alpha1 subunit of GABA(a) receptors in the olfactory bulb is crucial for rhythmic activity. Its absence alters synaptic inhibition and reduces network oscillations, highlighting receptor heterogeneity's functional impact.
Area of Science:
- Neuroscience
- Molecular Biology
- Computational Neuroscience
Background:
- Mitral and tufted cells in the olfactory bulb receive GABAergic inhibition via dendrodendritic synapses with granule cells.
- GABA(a) receptor subunit composition in these microcircuits exhibits variability, with differential expression of alpha1 and alpha3 subunits in different cell subtypes.
- Alpha1 subunit is expressed in all mitral cells, while alpha3 is found in a subset of mitral cells and tufted cells.
Purpose of the Study:
- To investigate the functional relevance of heterogeneous GABA(a) receptor subunit composition in olfactory bulb microcircuits.
- To assess the impact of alpha1 subunit deletion on synaptic inhibition and network oscillations.
Main Methods:
- Utilized a mouse model with a genetic deletion of the alpha1 subunit of GABA(a) receptors.
- Analyzed spontaneous and evoked inhibitory postsynaptic currents between granule and mitral cells.
- Measured field oscillations in the olfactory bulb network.
Main Results:
- Deletion of the alpha1 subunit led to partial compensation by alpha3-containing receptors in mitral cells, reducing inhibitory postsynaptic current frequency and prolonging decay.
- Evoked inhibition in alpha1 mutants showed slower kinetics and reduced amplitude.
- Significant reduction in the frequency of olfactory bulb field oscillations was observed in alpha1 mutants.
Conclusions:
- GABA(a) receptor subunit composition critically influences rhythmic activities in the olfactory bulb network.
- Dendrodendritic circuits in the external plexiform layer segregate into parallel pathways defined by distinct GABA(a) receptor expression in mitral and tufted cells.
- This heterogeneity in receptor composition has functional consequences for synaptic transmission and network dynamics.
More Related Videos
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:29Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...